Patient: LEMOINE, MARCIA MARIA Lab No: 2023-U62500874
Reference #:
Age: 69 years Gender: F Patient ID: 2023U62500874
Date of Birth: Jun 27 1954 Referring Site ID:
Address: 100 International Blvd.
HC #: 8933037833 Toronto, Ontario
Canada M9W 6J6
Patient's Phone: (289) 600-5266 Date of Service: Sep 07 2023 11:55
Telephone: (877) 849-3637
Reported on: Sep 08 2023 15:11 Toll Free: (877) 849-3637
Ordered by: RAMJEE DR. KARISHMA Fax: (905) 795-9891
Copy To:
Test Flag Result Reference Range - Units Lab Lic. #
General Comments
#5651
Reference Interval Note: Please note change in methodologies for routine
chemistry. Unless otherwise indicated, results
are equivalent and reference intervals remain
unchanged.
For a complete list of tests which have been
changed, please visit https://www.lifelabs.com
Hematology
#5687
WBC 7.0 4.0 - 11.0 x E9/L
RBC 4.45 4.00 - 5.10 x E12/L
Hemoglobin 146 120- 160 g/L
Hematocrit 0.416 0.350 - 0.450 L/L
MCV 94 80 - 100 fL
MCH 32.8 27.5 - 33.0 pg
MCHC 351 305 - 360 g/L
RDW 11.9 11.5 - 14.5 %
Platelet Count 225 150 - 400 x E9/L
Differential
Neutrophils 4.3 2.0 - 7.5 x E9/L
Lymphocytes 1.9 1.0 - 3.5 x E9/L
Monocytes 0.6 0.2 - 1.0 x E9/L
Eosinophils 0.1 0.0 - 0.5 x E9/L
Basophils 0.1 0.0 - 0.2 x E9/L
Immature Granulocytes 0.0 0.0 - 0.1 x E9/L
Nucleated RBC 0 /100 WBC
NOTE: As of JuLY 4, 2023 LifeLabs' pediatric
reference ranges have been updated to reflect the
following published resource: Bohn, et al.
Int J Lab Hematol. 2020;00:1-11.
Coagulation Studies
#5651
INR 1.0 0.9 - 1.2
Prothrombin Time
International Normalized Ratio Therapeutic Range
------------------------------------------------
Prophylaxis and treatment of
Thromboembolism 2.0 - 3.0
Patient with mechanical
prosthetic heart valve 2.5 - 3.5
Lab - 5687: LifeLabs, 100 International Blvd., Toronto, Ontario.
Lab - 5651: BELLEVILLE, 51 Adam Street, Belleville, Ontario.
Page 1 of 5
PARTIAL RESULTS
IMPORTANT: This report contains confidential information intended for view by authorized person(s) only and should be
disposed of securely (e.g. shredding) before discarding.
Note to Health Care Providers: This report has been printed by the patient.
Note to patients: Please contact your Health Care Provider if you have any questions regarding the results on this report.
Patient: LEMOINE, MARCIA MARIA Lab No: 2023-U62500874
Reference #:
Age: 69 years Gender: F Patient ID: 2023U62500874
Date of Birth: Jun 27 1954 Referring Site ID:
Address: 100 International Blvd.
HC #: 8933037833 Toronto, Ontario
Canada M9W 6J6
Patient's Phone: (289) 600-5266 Date of Service: Sep 07 2023 11:55
Telephone: (877) 849-3637
Reported on: Sep 08 2023 15:11 Toll Free: (877) 849-3637
Ordered by: RAMJEE DR. KARISHMA Fax: (905) 795-9891
Copy To:
Test Flag Result Reference Range - Units Lab Lic. #
Biochemical Investigation of Anemias
#5687
Vitamin B12 528 138-652 pmol/L
>220 pmol/L: Normal, deficiency unlikely
150-220 pmol/L: Borderline,deficiency is possible
<150 pmol/L: Low, consistent with deficiency
Ferritin 177 15-272 ug/L
<15 ug/L: diagnostic of iron deficiency
15-30 ug/L: probable iron deficiency
>30 ug/L: iron deficiency unlikely
>100 ug/L: normal iron stores
=>600 ug/L: consider test for iron overload
Effective Oct 24, 2022 this test is performed on
a new analyzer. Results are equivalent and
reference intervals are updated as per clinical
guidelines.
General Chemistry
#5651
Glucose Fasting 4.6 3.6 - 6.0 mmol/L
#5687
Hemoglobin A1C/Total Hemoglobin 5.3 <6.0 %
Diabetes Canada 2018 Guidelines:
--------------------------------------------------
Screening and Diagnosis: < 5.5 % Normal
5.5% - 5.9 % At risk
6.0% - 6.4 % Prediabetes
>OR= 6.5 % Diabetes Mellitus
If HbA1c >OR= 6.5 % and asymptomatic, confirm
using Fasting Glucose, HbA1c or 75g OGTT.
--------------------------------------------------
Monitoring: <OR= 7.0 %
Target in adults without comorbidities. Other
targets may be more appropriate in children,
elderly and patients with comorbidities.
--------------------------------------------------
Results may not accurately reflect mean blood
glucose in patients with hemoglobin variants,
disorders associated with abnormal erythrocyte
turnover, severe renal and liver disorders.
Lab - 5687: LifeLabs, 100 International Blvd., Toronto, Ontario.
Lab - 5651: BELLEVILLE, 51 Adam Street, Belleville, Ontario.
Page 2 of 5
PARTIAL RESULTS
IMPORTANT: This report contains confidential information intended for view by authorized person(s) only and should be
disposed of securely (e.g. shredding) before discarding.
Note to Health Care Providers: This report has been printed by the patient.
Note to patients: Please contact your Health Care Provider if you have any questions regarding the results on this report.
Patient: LEMOINE, MARCIA MARIA Lab No: 2023-U62500874
Reference #:
Age: 69 years Gender: F Patient ID: 2023U62500874
Date of Birth: Jun 27 1954 Referring Site ID:
Address: 100 International Blvd.
HC #: 8933037833 Toronto, Ontario
Canada M9W 6J6
Patient's Phone: (289) 600-5266 Date of Service: Sep 07 2023 11:55
Telephone: (877) 849-3637
Reported on: Sep 08 2023 15:11 Toll Free: (877) 849-3637
Ordered by: RAMJEE DR. KARISHMA Fax: (905) 795-9891
Copy To:
Test Flag Result Reference Range - Units Lab Lic. #
General Chemistry
#5651
Sodium 141 135-145 mmol/L
Potassium 4.2 3.5-5.2 mmol/L
Creatinine 71 50-100 umol/L
Glomerular Filtration Rate (eGFR) 75
An eGFR from 60-89 ml/min/1.73 m2 is consistent
with mildly decreased kidney function. However,
in the absence of other evidence of kidney
disease, eGFR values in this range do not fulfill
the KDIGO criteria for chronic kidney disease.
Interpret results in concert with ACR measurement.
Effective May 4 2015, eGFR is calculated using
the CKD-EPI 2009 equation.
KDIGO 2012 guidelines highlight the importance of
eGFR and urine albumin creatinine ratio (ACR) in
screening, diagnosis and management of CKD.
Results for eGFR should be interpreted in concert
with ACR.
Calcium 2.33 2.15-2.60 mmol/L
Albumin 39 35-52 g/L
Bilirubin Total HI 23 <20 umol/L
Bilirubin Glucuronidated (Direct) Results are pending ...
Indirect Bilirubin
Bilirubin Total HI 23 <20 umol/L
Lab - 5687: LifeLabs, 100 International Blvd., Toronto, Ontario.
Lab - 5651: BELLEVILLE, 51 Adam Street, Belleville, Ontario.
Page 3 of 5
PARTIAL RESULTS
IMPORTANT: This report contains confidential information intended for view by authorized person(s) only and should be
disposed of securely (e.g. shredding) before discarding.
Note to Health Care Providers: This report has been printed by the patient.
Note to patients: Please contact your Health Care Provider if you have any questions regarding the results on this report.
Patient: LEMOINE, MARCIA MARIA Lab No: 2023-U62500874
Reference #:
Age: 69 years Gender: F Patient ID: 2023U62500874
Date of Birth: Jun 27 1954 Referring Site ID:
Address: 100 International Blvd.
HC #: 8933037833 Toronto, Ontario
Canada M9W 6J6
Patient's Phone: (289) 600-5266 Date of Service: Sep 07 2023 11:55
Telephone: (877) 849-3637
Reported on: Sep 08 2023 15:11 Toll Free: (877) 849-3637
Ordered by: RAMJEE DR. KARISHMA Fax: (905) 795-9891
Copy To:
Test Flag Result Reference Range - Units Lab Lic. #
General Chemistry
Alkaline Phosphatase 101 35-120 U/L
Gamma Glutamyl Transferase 13 <44 U/L
Effective May 29, 2023 this test is performed on
a new analyzer. Reference interval has been
updated.
Alanine Aminotransferase 15 <36 U/L
Aspartate Aminotransferase 24 <30 U/L
Effective May 29, 2023 this test is performed on
a new analyzer; reported values might show up
to 14% increase. Reference intervals are
unchanged.
Magnesium 0.85 0.70-1.00 mmol/L
Lipase 16 <60 U/L
Effective May 29, 2023 this test is performed on
a new analyzer; reported values might show up to
15% decrease. Reference intervals are unchanged.
Lipids
Hours After Meal 16 Hours
Triglyceride 0.52 mmol/L
FASTING: <1.70 mmol/L
NON-FASTING: <2.00 mmol/L
Cholesterol HI 5.82 <5.20 mmol/L
Total cholesterol and HDL-C used for risk
assessment and to calculate non HDL-C.
HDL Cholesterol 1.92 >=1.30 mmol/L
HDL-C <1.30 mmol/L indicates risk for metabolic
syndrome.
Non HDL Cholesterol 3.90 <4.20 mmol/L
Non HDL-Cholesterol is not affected by the
fasting status of the patient.
LDL Cholesterol HI 3.70 <3.50 mmol/L
If LDL-C >=3.50 mmol/L in primary prevention
setting for low risk patients (FRS 5-9.9%) or
intermediate risk patients (FRS 10-20%), consider
therapy. Therapy also suggested in low risk
patients (FRS <10%) with LDL-C >4.99 mmol/L.
LDL-C is calculated using the NIH equation.
For additional LDL-C and non-HDL-C thresholds
based on risk stratification, refer to 2021 CCS
Guidelines. Can J Cardiol. 2021;37(8):1129-1150.
Effective May 29, 2023 please note a change in
decision limits that align with current clinical
Lab - 5687: LifeLabs, 100 International Blvd., Toronto, Ontario.
Lab - 5651: BELLEVILLE, 51 Adam Street, Belleville, Ontario.
Page 4 of 5
PARTIAL RESULTS
IMPORTANT: This report contains confidential information intended for view by authorized person(s) only and should be
disposed of securely (e.g. shredding) before discarding.
Note to Health Care Providers: This report has been printed by the patient.
Note to patients: Please contact your Health Care Provider if you have any questions regarding the results on this report.
Patient: LEMOINE, MARCIA MARIA Lab No: 2023-U62500874
Reference #:
Age: 69 years Gender: F Patient ID: 2023U62500874
Date of Birth: Jun 27 1954 Referring Site ID:
Address: 100 International Blvd.
HC #: 8933037833 Toronto, Ontario
Canada M9W 6J6
Patient's Phone: (289) 600-5266 Date of Service: Sep 07 2023 11:55
Telephone: (877) 849-3637
Reported on: Sep 08 2023 15:11 Toll Free: (877) 849-3637
Ordered by: RAMJEE DR. KARISHMA Fax: (905) 795-9891
Copy To:
Test Flag Result Reference Range - Units Lab Lic. #
Lipids
guidelines. In addition, Friedevald LDL-C
equation is replaced by the new NIH LDL-C
equation that has improved accuracy when
triglycerides are high and/or LDL-C is low.
Cholesterol/HDL Ratio 3.0
Cholesterol/HDL-C is not included in the 2021 CCS
guideline as a lipid initiation or treatment
target but is recognized as an indicator of high
CVD risk at Cholesterol/HDL-C ratio >6.0
Thyroid Function
#5687
Thyroid Stimulating Hormone 1.84 0.32-4.00 mIU/L
Free T4 11 9-19 pmol/L
Immunology
Celiac Screening
Immunoglobulin IgA 3.13 0.54-4.17 g/L
Serology
Helicobacter pylori Ab
Helicobacter pylori IgG Ab 0.32 <0.80 Index
A result less than 0.80 Index value is considered
"negative" and indicates that H.pylori IgG
antibodies were not detected in the sample.
Negative results do not preclude recent primary
infection.
Lab - 5687: LifeLabs, 100 International Blvd., Toronto, Ontario.
Lab - 5651: BELLEVILLE, 51 Adam Street, Belleville, Ontario.
Page 5 of 5
PARTIAL RESULTS
IMPORTANT: This report contains confidential information intended for view by authorized person(s) only and should be
disposed of securely (e.g. shredding) before discarding.
Note to Health Care Providers: This report has been printed by the patient.
Note to patients: Please contact your Health Care Provider if you have any questions regarding the results on this report.
